Skip to main content
. 2020 Jan 7;2020:6759808. doi: 10.1155/2020/6759808

Figure 1.

Figure 1

α-Lipoic acid (ALA) was administered daily for 7 d prior to a reperfused, 45-minute coronary occlusion. Two doses were examined: 15 and 75 mg/kg·day. Mean infarct size (% risk region) in ALA-treated mice was reduced by a minimum of 30% relative to control mice. P < 0.05 as compared with the H2O-treated group.